This is a StreetInsider.com Premium Only Page

Momenta Phama (MNTA) – Analyst EPS Change

Oct 4, 2017 12:02 PM Momenta Pharmaceuticals (MNTA) PT Lowered to $16 at Barclays; 'More Conservative Stance on Eventual (Generic Copaxone 40mg) Market Share'

May 2, 2017 02:36 PM Momenta Pharmaceuticals (MNTA) PT Lowered to $26 at Stifel on 1Q Results; 'Patents & Production Issues Continue'

Jan 6, 2017 06:22 AM

Nov 9, 2015 11:33 AM

Aug 5, 2015 09:57 AM

Aug 5, 2015 07:58 AM

Jun 19, 2015 07:46 AM

Jul 20, 2012 12:34 PM

Jun 26, 2012 11:05 AM